Incyte Corporation

Incyte Corporation, a pharmaceutical manufacturing company, provides Jakafi® (ruxolitinib) for treating adults with polycythemia vera, certain types of myelofibrosis, and acute or chronic graft-versus-host disease in patients aged 12 and older who have not responded adequately to prior treatments.